Developer docs
API playgroundTry for free, no card

Search company profiles

NM PHARMA

Full company profile

uuid02ly9ii

Namestring
NM PHARMA
Legal namestring
NMPharma Malta
Websiteurl
nmpharma.com.mt
Company typeenum
Private
Founded yearstring
-
Descriptiontext

NM Pharma (NMPharma Malta) is a privately held Maltese pharmaceutical company that imports, distributes, wholesales, and exports prescription medications, OTC products, food supplements, controlled substances, vaccines, and medical devices. The company serves three customer segments: (i) the private healthcare market in Malta and Gozo through a field sales team covering 229 pharmacies (including 6 in-house pharmacies), 5 private hospitals, 15 private clinics, and 25 dental clinics; (ii) Malta's National Health Service via tenders and urgent calls issued by the Central Procurement & Supplies Unit; and (iii) international export customers across the UK, Netherlands, France, Ireland, Italy, Spain, Romania, Greece, North Africa, and Asia, which the company identifies as its fastest-growing segment.

Operations are anchored by a 1,500 sqm centralized distribution centre in Malta with capacity for over 500 pallets, EU Goods Distribution Practice (GDP) compliance, precise temperature control, and a dedicated cold room for cold-chain products. The company holds an in-house Good Manufacturing Practice (GMP) license from the Malta Medicines Authority for pharmaceutical relabeling across two production lines, enabling over-labeling, primary labeling, and package insert replacement. This license gives the company procurement flexibility across EU member states. NM Pharma also owns six consumer brands (Hydratis, Linea Act, Medi Drink Neo, Mio Magnesio, Quies, Zymerex) distributed via an e-commerce storefront with home delivery and warehouse collection options across Malta and Gozo.

The revenue model is transaction-based across all four streams: private-market distribution, NHS tenders, export sales, and direct-to-consumer e-commerce. Pricing on the consumer channel ranges from approximately €3.75 to €74.99 per unit, with free delivery over €30 and a 5% warehouse-collection discount. Marketing is primarily digital via the corporate website, Facebook, and Instagram. No revenue, headcount, ownership, or funding data is publicly disclosed.

Short descriptiontext

NM Pharma is a privately held Maltese pharmaceutical importer, distributor, wholesaler, and exporter serving 229 Maltese pharmacies, hospitals, clinics, and dental practices, plus Malta's NHS tenders and international customers across Europe, North Africa, and Asia from a GMP-licensed centralized facility.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical distribution, pharmaceutical import export, healthcare product wholesale, medical device distribution, pharmaceutical relabeling services
Industry3 codes
PRIMARYCRAOAHAA
Prescription Pharmaceutical (Rx) Wholesale Distribution
SECONDARYHLAIAJAF
Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
NAICS code2 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
  • Drugs and Druggists' Sundries Merchant Wholesalers4242
SIC code2 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Pharmaceutical Distribution
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Pharmaceutical Distribution
TypeTransaction Fee
Description

Distribution of prescription medications, OTC products, food supplements, controlled substances, vaccines, and medical devices to pharmacies, hospitals, clinics, and dental practices throughout Malta and Gozo

nmpharma.com.mt
2Government Healthcare Contracts
TypeTransaction Fee
Description

Participation in government tenders issued by Malta's NHS Central Procurement & Supplies Unit for acquisition of pharmaceuticals and medical equipment

nmpharma.com.mt
3Export
TypeTransaction Fee
Description

Export of pharmaceuticals including low-cost generics to high-end vaccines, serving customers in UK, Netherlands, France, Ireland, Italy, Spain, Romania, Greece, North Africa, Asia, and other EU countries. Fastest-growing business segment.

nmpharma.com.mt
4Direct-to-Consumer E-commerce
TypeTransaction Fee
Description

Online retail sales of food supplements and health products to individual consumers via company e-commerce platform

nmpharma.com.mt
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure, Technology or R&D
Pricing details1 tier
1Standard product pricing (€3.75 - €74.99)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Individual product pricing varies by brand and formulation. Examples: Zymerex Collagen Gummies €19.90, Mio Magnesio varieties €8.99, Quies earplugs from €3.75, Medi Drink Neo €74.99

nmpharma.com.mt
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 6 records shown
1Hydratis
Description

Brand of pharmaceutical/health products

nmpharma.com.mt
+5 more records
Core offering1 text field

NM Pharma distributes, wholesales, and exports pharmaceuticals, medical devices, and related healthcare products from its centralized distribution centre in Malta, holding a GMP license for in-house pharmaceutical relabeling. The company serves private healthcare providers (pharmacies, hospitals, clinics, dental practices), Malta's National Health Service through government tenders, and international export customers across Europe, North Africa, and Asia. It also retails a portfolio of six proprietary health supplement and wellness brands (Hydratis, Linea Act, Medi Drink Neo, Mio Magnesio, Quies, Zymerex) through its own e-commerce platform.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

NM Pharma is a Maltese pharmaceutical import, export, and distribution company operating from a centralized distribution centre. The company offers a diverse portfolio of pharmaceutical and health products across six main brands: Hydratis (hydration supplements), Linea Act (comprehensive food supplements including vitamins, minerals, probiotics, sleep aids, respiratory care, and weight management), Medi Drink Neo (medical nutritional drinks), Mio Magnesio (various magnesium formulations), Quies (ear care products including earplugs and ear hygiene), and Zymerex (digestive health supplements). The company also provides regulatory services including pharmaceutical relabeling under GMP license from Malta Medicines Authority, serves the National Health Service through tender participation, and exports throughout Europe and beyond.

Product and service10 records
1Hydratis
CategoryFood Supplements
Description

A proprietary brand of hydration and wellness food supplements distributed by NM Pharma via its e-commerce platform.

2Linea Act
3Medi Drink Neo
4Mio Magnesio
5Quies
6Zymerex
7Pharmaceutical Distribution to Private Healthcare Providers
8NHS Malta Government Tender Supply
9International Pharmaceutical Export
10GMP-Licensed Pharmaceutical Relabeling
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Mawdsleys is a UK-based specialist pharmaceutical distributor focused on cross-border supply, including controlled substances and products for export markets. It is comparable to NM Pharma as a mid-sized UK-rooted exporter with strong supplier networks into Europe, Africa, and Asia, mirroring NM Pharma's export-sourcing business model.

TypeDirect peer
Description

Mediq is a European healthcare distributor and solutions provider focused on medical devices, pharmaceuticals, and home care supplies across multiple EU markets. It is a relevant comparable as a multi-country European pharma/medical device distributor with cross-border logistics, similar to NM Pharma's diversified portfolio across Rx, OTC, supplements, and devices.

TypeBroad incumbent
Description

PHOENIX Group is one of the largest pharmaceutical distribution groups in Europe, with operations across wholesale, retail pharmacy (including the Benavente, Lloyds partnerships), and pharma pre-wholesale. It is comparable as a continent-wide pharma wholesaler that competes with NM Pharma on cross-border sourcing for export customers and targets similar pharmacy and hospital end markets.

4McKesson Europe (formerly LloydsPharmacy Distribution)
TypeBroad incumbent
Description

McKesson Europe operates pharmaceutical wholesale and retail pharmacy businesses across multiple European countries, sourcing and distributing prescription, OTC, and specialty products. It competes with NM Pharma in cross-border EU pharmaceutical supply and offers overlapping service lines including GDP-compliant warehousing and supplier-network intermediation.

5European Pharma Group (EPG) / Surgipharm-style independent distributors
TypeEmerging player
Description

Surgipharm is an independent pharmaceutical distributor operating in frontier and emerging markets with cross-border sourcing from European suppliers. It is comparable to NM Pharma as a smaller pharma importer-distributor that competes in similar cross-border supply chains into Africa and other emerging regions where NM Pharma is expanding.

TypeDirect peer
Description

Oriola is a Finnish-listed pharmaceutical distributor and retail pharmacy operator serving pharmacies, hospitals, and healthcare providers in the Nordics and Baltics, with comparable wholesale-plus-brands-plus-pharmacy mix. It is relevant as a similarly structured mid-sized European pharma distributor operating across multiple countries, analogous to NM Pharma's domestic-plus-export positioning.

TypeBroad incumbent
Description

Cencora is a global pharmaceutical solutions company providing distribution, consulting, and specialty services across human and animal health markets. It is a broad incumbent peer that competes with mid-sized distributors like NM Pharma, particularly on specialty pharmaceuticals, vaccines, and international sourcing for emerging markets.

TypeBroad incumbent
Description

Alliance Healthcare is a leading European pharmaceutical wholesaler serving pharmacies, hospitals, and clinics across multiple EU countries, with distribution, pre-wholesale, and healthcare services. It is comparable to NM Pharma as a wide-portfolio EU pharma distributor, though considerably larger in scale and geographic reach than NM Pharma's Maltese footprint.

TypeDirect peer
Description

Tamro is a Nordic pharmaceutical distributor (now part of PHOENIX Group) that supplies pharmacies, hospitals, and healthcare providers across Finland, the Baltics, and broader Europe. It is a relevant peer given similar role as regional pharma distributor with growth ambitions outside its home market, mirroring NM Pharma's Malta-centric but export-ambitious model.

TypeEmerging player
Description

Smartway Pharma operates cross-border pharmaceutical distribution between regulated and emerging markets, leveraging supplier networks in Europe. It is comparable to NM Pharma as a mid-sized distributor spanning Europe-to-Asia and Europe-to-Africa flows, with a similar sourcing-and-reselling model into markets with complex regulatory requirements.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NM PHARMA

Pharmaceutical Distributionnmpharma.com.mt

NM Pharma is a privately held Maltese pharmaceutical importer, distributor, wholesaler, and exporter serving 229 Maltese pharmacies, hospitals, clinics, and dental practices, plus Malta's NHS tenders and international customers across Europe, North Africa, and Asia from a GMP-licensed centralized facility.

What NM PHARMA does

NM Pharma (NMPharma Malta) is a privately held Maltese pharmaceutical company that imports, distributes, wholesales, and exports prescription medications, OTC products, food supplements, controlled substances, vaccines, and medical devices. The company serves three customer segments: (i) the private healthcare market in Malta and Gozo through a field sales team covering 229 pharmacies (including 6 in-house pharmacies), 5 private hospitals, 15 private clinics, and 25 dental clinics; (ii) Malta's National Health Service via tenders and urgent calls issued by the Central Procurement & Supplies Unit; and (iii) international export customers across the UK, Netherlands, France, Ireland, Italy, Spain, Romania, Greece, North Africa, and Asia, which the company identifies as its fastest-growing segment.

Operations are anchored by a 1,500 sqm centralized distribution centre in Malta with capacity for over 500 pallets, EU Goods Distribution Practice (GDP) compliance, precise temperature control, and a dedicated cold room for cold-chain products. The company holds an in-house Good Manufacturing Practice (GMP) license from the Malta Medicines Authority for pharmaceutical relabeling across two production lines, enabling over-labeling, primary labeling, and package insert replacement. This license gives the company procurement flexibility across EU member states. NM Pharma also owns six consumer brands (Hydratis, Linea Act, Medi Drink Neo, Mio Magnesio, Quies, Zymerex) distributed via an e-commerce storefront with home delivery and warehouse collection options across Malta and Gozo.

The revenue model is transaction-based across all four streams: private-market distribution, NHS tenders, export sales, and direct-to-consumer e-commerce. Pricing on the consumer channel ranges from approximately €3.75 to €74.99 per unit, with free delivery over €30 and a 5% warehouse-collection discount. Marketing is primarily digital via the corporate website, Facebook, and Instagram. No revenue, headcount, ownership, or funding data is publicly disclosed.

NM PHARMA firmographics

Firmographics
Name
NM PHARMA
Legal name
NMPharma Malta
Website
https://nmpharma.com.mt
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
NM Pharma is a privately held Maltese pharmaceutical importer, distributor, wholesaler, and exporter serving 229 Maltese pharmacies, hospitals, clinics, and dental practices, plus Malta's NHS tenders and international customers across Europe, North Africa, and Asia from a GMP-licensed centralized facility.
Ownership category
akta.pro rank

NM PHARMA industry classification

Industry
Product category
Pharmaceutical Distribution
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (4242)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYCRAOAHAA
Prescription Pharmaceutical (Rx) Wholesale Distribution
SECONDARYHLAIAJAF
Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences

Keywords

  • Pharmaceutical distribution
  • Pharmaceutical import export
  • Healthcare product wholesale
  • Medical device distribution
  • Pharmaceutical relabeling services

NM PHARMA business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

  1. Pharmaceutical Distribution: Distribution of prescription medications, OTC products, food supplements, controlled substances, vaccines, and medical devices to pharmacies, hospitals, clinics, and dental practices throughout Malta and Gozo
  2. Government Healthcare Contracts: Participation in government tenders issued by Malta's NHS Central Procurement & Supplies Unit for acquisition of pharmaceuticals and medical equipment
  3. Export: Export of pharmaceuticals including low-cost generics to high-end vaccines, serving customers in UK, Netherlands, France, Ireland, Italy, Spain, Romania, Greece, North Africa, Asia, and other EU countries. Fastest-growing business segment.
  4. Direct-to-Consumer E-commerce: Online retail sales of food supplements and health products to individual consumers via company e-commerce platform

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard product pricing (€3.75 - €74.99)

Go-to-market motion2 records

Distribution channels4 records

Marketing channels3 records

NM PHARMA product offering

Product offering

Core offering

NM Pharma distributes, wholesales, and exports pharmaceuticals, medical devices, and related healthcare products from its centralized distribution centre in Malta, holding a GMP license for in-house pharmaceutical relabeling. The company serves private healthcare providers (pharmacies, hospitals, clinics, dental practices), Malta's National Health Service through government tenders, and international export customers across Europe, North Africa, and Asia. It also retails a portfolio of six proprietary health supplement and wellness brands (Hydratis, Linea Act, Medi Drink Neo, Mio Magnesio, Quies, Zymerex) through its own e-commerce platform.

Product overview

NM Pharma is a Maltese pharmaceutical import, export, and distribution company operating from a centralized distribution centre. The company offers a diverse portfolio of pharmaceutical and health products across six main brands: Hydratis (hydration supplements), Linea Act (comprehensive food supplements including vitamins, minerals, probiotics, sleep aids, respiratory care, and weight management), Medi Drink Neo (medical nutritional drinks), Mio Magnesio (various magnesium formulations), Quies (ear care products including earplugs and ear hygiene), and Zymerex (digestive health supplements). The company also provides regulatory services including pharmaceutical relabeling under GMP license from Malta Medicines Authority, serves the National Health Service through tender participation, and exports throughout Europe and beyond.

Differentiator

Problem solved

Functional benefit

Brands

  • Hydratis: Brand of pharmaceutical/health products
  • Linea Act
  • Medi Drink Neo
  • Mio Magnesio
  • Quies
  • Zymerex

Products and services

  • Hydratis A proprietary brand of hydration and wellness food supplements distributed by NM Pharma via its e-commerce platform.
  • Linea Act
  • Medi Drink Neo
  • Mio Magnesio
  • Quies
  • Zymerex
  • Pharmaceutical Distribution to Private Healthcare Providers
  • NHS Malta Government Tender Supply
  • International Pharmaceutical Export
  • GMP-Licensed Pharmaceutical Relabeling

Companies that use NM PHARMA

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

NM PHARMA technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature2 records

NM PHARMA partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

NM PHARMA competitors and assessment

Company assessment

Direct peers

  • Mawdsleys: Mawdsleys is a UK-based specialist pharmaceutical distributor focused on cross-border supply, including controlled substances and products for export markets. It is comparable to NM Pharma as a mid-sized UK-rooted exporter with strong supplier networks into Europe, Africa, and Asia, mirroring NM Pharma's export-sourcing business model.
  • Mediq: Mediq is a European healthcare distributor and solutions provider focused on medical devices, pharmaceuticals, and home care supplies across multiple EU markets. It is a relevant comparable as a multi-country European pharma/medical device distributor with cross-border logistics, similar to NM Pharma's diversified portfolio across Rx, OTC, supplements, and devices.
  • Oriola Corporation: Oriola is a Finnish-listed pharmaceutical distributor and retail pharmacy operator serving pharmacies, hospitals, and healthcare providers in the Nordics and Baltics, with comparable wholesale-plus-brands-plus-pharmacy mix. It is relevant as a similarly structured mid-sized European pharma distributor operating across multiple countries, analogous to NM Pharma's domestic-plus-export positioning.
  • Tamro (PHOENIX Group subsidiary): Tamro is a Nordic pharmaceutical distributor (now part of PHOENIX Group) that supplies pharmacies, hospitals, and healthcare providers across Finland, the Baltics, and broader Europe. It is a relevant peer given similar role as regional pharma distributor with growth ambitions outside its home market, mirroring NM Pharma's Malta-centric but export-ambitious model.

Broad incumbents

  • PHOENIX Group: PHOENIX Group is one of the largest pharmaceutical distribution groups in Europe, with operations across wholesale, retail pharmacy (including the Benavente, Lloyds partnerships), and pharma pre-wholesale. It is comparable as a continent-wide pharma wholesaler that competes with NM Pharma on cross-border sourcing for export customers and targets similar pharmacy and hospital end markets.
  • McKesson Europe (formerly LloydsPharmacy Distribution): McKesson Europe operates pharmaceutical wholesale and retail pharmacy businesses across multiple European countries, sourcing and distributing prescription, OTC, and specialty products. It competes with NM Pharma in cross-border EU pharmaceutical supply and offers overlapping service lines including GDP-compliant warehousing and supplier-network intermediation.
  • Cencora (formerly AmerisourceBergen): Cencora is a global pharmaceutical solutions company providing distribution, consulting, and specialty services across human and animal health markets. It is a broad incumbent peer that competes with mid-sized distributors like NM Pharma, particularly on specialty pharmaceuticals, vaccines, and international sourcing for emerging markets.
  • Alliance Healthcare: Alliance Healthcare is a leading European pharmaceutical wholesaler serving pharmacies, hospitals, and clinics across multiple EU countries, with distribution, pre-wholesale, and healthcare services. It is comparable to NM Pharma as a wide-portfolio EU pharma distributor, though considerably larger in scale and geographic reach than NM Pharma's Maltese footprint.

Emerging players

  • European Pharma Group (EPG) / Surgipharm-style independent distributors: Surgipharm is an independent pharmaceutical distributor operating in frontier and emerging markets with cross-border sourcing from European suppliers. It is comparable to NM Pharma as a smaller pharma importer-distributor that competes in similar cross-border supply chains into Africa and other emerging regions where NM Pharma is expanding.
  • Smartway Pharma India (cross-border distribution example): Smartway Pharma operates cross-border pharmaceutical distribution between regulated and emerging markets, leveraging supplier networks in Europe. It is comparable to NM Pharma as a mid-sized distributor spanning Europe-to-Asia and Europe-to-Africa flows, with a similar sourcing-and-reselling model into markets with complex regulatory requirements.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

NM PHARMA social profiles

Digital presence

NM PHARMA compliance and trust

Trust signal

Compliance2 records

NM PHARMA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NM PHARMA leadership team

Management profile

Number of profiles

NM PHARMA funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NM PHARMA M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NM PHARMA

What does NM PHARMA do?

NM Pharma distributes, wholesales, and exports pharmaceuticals, medical devices, and related healthcare products from its centralized distribution centre in Malta, holding a GMP license for in-house pharmaceutical relabeling. The company serves private healthcare providers (pharmacies, hospitals, clinics, dental practices), Malta's National Health Service through government tenders, and international export customers across Europe, North Africa, and Asia. It also retails a portfolio of six proprietary health supplement and wellness brands (Hydratis, Linea Act, Medi Drink Neo, Mio Magnesio, Quies, Zymerex) through its own e-commerce platform.

Is NM PHARMA a public or private company?

NM PHARMA is a private company. It is classified as unknown and is currently operating.

When was NM PHARMA founded?

NM PHARMA was founded in -1. It employs 1 to 10 people.

How does NM PHARMA make money?

Four revenue lines are on record. Pharmaceutical Distribution is the primary driver. The others are government Healthcare Contracts, export and direct-to-Consumer E-commerce.

Who are NM PHARMA's main competitors?

Direct peers on record are Mawdsleys, Mediq, Oriola Corporation and Tamro (PHOENIX Group subsidiary). Broad incumbents are PHOENIX Group, McKesson Europe (formerly LloydsPharmacy Distribution), Cencora (formerly AmerisourceBergen) and Alliance Healthcare. Emerging players are European Pharma Group (EPG) / Surgipharm-style independent distributors and Smartway Pharma India (cross-border distribution example).

Does NM PHARMA have an API?

No public API is recorded for NM PHARMA.

What industry is NM PHARMA in?

NM PHARMA's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution, with a secondary code of HLAIAJAF, Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor). Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales